Clinical Trial Update: The Value of Oral Micronized Progesterone in the Prevention of Spontaneous Preterm Birth [Phase 4]

View source ↗

Summary

This document provides an update on a Phase 4 clinical trial evaluating the use of oral micronized progesterone to prevent spontaneous preterm birth.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Birth

Drugs mentioned

• Oral micronized progesterone (progesterone)

Snippet

Sponsor: Ghamra Military Hospital | Conditions: Preterm Birth | Phase 4 | Status: UNKNOWN